EyeGene Inc. (KOSDAQ:185490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,940.00
+14.00 (0.73%)
At close: Sep 3, 2026

EyeGene Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16,219-15,706-12,128-21,106-25,953-34,569
Depreciation & Amortization
2,0772,0772,3432,1371,2911,070
Loss (Gain) From Sale of Assets
846.61846.61543.4627.65-1.814.18
Asset Writedown & Restructuring Costs
2,0992,099-82.57--
Loss (Gain) From Sale of Investments
6,3246,324-12.051,539776.79-432.18
Loss (Gain) on Equity Investments
85.9685.96-10.28168.9623.21-
Stock-Based Compensation
362.31362.31-924.681,8733,8661,363
Provision & Write-off of Bad Debts
-2-216.06---
Other Operating Activities
-3,911-1,940695.89-4,5943,1701,564
Change in Accounts Receivable
644.58644.58-936.07430.01-166.76110.59
Change in Inventory
-165.73-165.73-529.78442.8276.39-69.91
Change in Accounts Payable
-378.11-378.111,209-393.15-1,030364.01
Change in Other Net Operating Assets
-229.31-229.31-2,438-728.21-819.05590.86
Operating Cash Flow
-8,465-5,981-12,171-20,120-18,568-30,004
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-104.85-102.69-1,514-1,385-767.86-2,378
Sale of Property, Plant & Equipment
-950-95.36-
Cash Acquisitions
-----800-
Sale (Purchase) of Intangibles
-1,116-1,120-3,472-280.67-138.51-325.62
Investment in Securities
-6,097-3,67313,9337,32918,950-54,498
Other Investing Activities
-0-1,410-1,608-0-0524.7
Investing Cash Flow
-7,317-5,3567,3385,67217,249-56,677

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--2,155-309.43-551.33-3,303-1,273
Net Debt Issued (Repaid)
-2,154-2,155-309.43-551.33-3,303-1,273
Issuance of Common Stock
22,11522,115-14,980-88,186
Other Financing Activities
-7.75107.06147.07491.354,183-289.01
Financing Cash Flow
19,95420,068646.5217,909879.9786,624

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
148.138.23116.1-10.2-164.41-16.96
Net Cash Flow
4,3198,769-4,0713,450-603.17-74.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8,570-6,084-13,685-21,506-19,336-32,382
Free Cash Flow Growth
------
Free Cash Flow Margin
-213.13%-170.57%-407.82%-688.10%-365.27%-998.79%
Free Cash Flow Per Share
-267.59-217.57-506.65-993.54-901.68-1709.67
Levered Free Cash Flow
-6,288-4,359-11,976-11,426-15,529-20,460
Unlevered Free Cash Flow
-5,895-3,966-11,539-11,136-15,282-19,364

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
44.4946.8358.1755.2-8.51
Cash Income Tax Paid
--95.17-79.84106.81147.41-13.65
Change in Working Capital
-128.58-128.58-2,695-248.55-1,740995.55